Although leukocyte rolling was not affected in the
sdc1 −/− mouse in vivo, a strong adhesion to the retinal vascular endothelium was observed in the
sdc1 −/− mouse. The bone marrow transplantation experiments show that this effect is largely leukocyte dependent, although we cannot completely rule out an endothelial component, because of a high SE in the group in which wild-type leukocytes were transplanted into knockout animals. Most leukocytes did not express syndecan-1 on their surfaces in an unstimulated state; however, in some instances, syndecan-1 expression could be induced by inflammatory stimuli, as it is the case in macrophages
19 and LPS-stimulated B lymphocytes (Klein, unpublished data, 2000). In fact, a temporally restricted and highly regulated expression is a hallmark of syndecan-1’s function during embryonic development and wound healing.
4 5 In addition, it has to be noted that the intact ectodomain of syndecan-1 can be proteolytically cleaved from the cell surface in a regulated manner.
43 The syndecan-1 ectodomain has been shown to act as a soluble effector, both in a physiological and pathologic context.
44 45 One could envisage that syndecan-1, shed from the surface of activated endothelial cells, binds to chemokines and attenuates their function. In the
sdc1 −/− mouse, the absence of soluble syndecan-1 could lead to a dysregulation and potentiation of chemokine action. Because chemokines induce or activate a variety of adhesion molecules on leukocyte surfaces, this would have a profound effect on leukocyte properties and their function. In addition, soluble syndecan-1 derived from noncirculating cells could bind to and block heparin-binding sites of adhesion molecules on the leukocyte surface of
sdc1 +/+ mice. The absence of syndecan-1 in
sdc1 −/− mice would lead to an exposure of these sites and to a more efficient binding to endothelial receptor molecules. In the retinal vasculature, increased adhesion is mediated through integrins or CAMs rather than selectins (Adamis, unpublished data, 1999) in conditions such as experimental diabetic retinopathy. Similar mechanisms seem to contribute to the leukostasis in the
sdc1 −/− mouse. This effect could be due to a more efficient activation of integrins through chemokines. It has recently been shown that syndecans can indeed influence integrin signaling.
46 The absence of syndecan-1 leads to a phenotype resembling early changes in diabetic retinopathy in the retina. For diabetic retinopathy, we have previously shown that inhibition of leukocyte–endothelial interaction through specific blockade of ICAM-1 or CD-18 leads to a subsequent reduction of increased leukostasis as well as the associated endothelial cell death and vascular leakage.
2 3 The concept of an inhibitory role of syndecan-1 on leukocyte adhesion is supported by our data on corneal angiogenesis. Absence of syndecan-1 leads to an increased angiogenic response; however, absence of ICAM or CD-18 reduces the inflammatory response.
1